1 Min Read
Sept 28 (Reuters) - Ctd Holdings Inc
* CTD Holdings enrolls first patient in U.S. phase I clinical trial of Trappsol(r) Cyclo(tm) for treatment of Niemann-Pick disease type C Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.